Age-adjusted high-dose chemotherapy followed by autologous stem cell transplantation or conventional chemotherapy with R-MP as first-line treatment in elderly primary CNS lymphoma patients - the randomized phase III PRIMA-CNS trial

  • Ghanem, Riad (Researcher)
  • Kausche, Lea Elisabeth (Researcher)
  • Klein, Katharina (Researcher)
  • Kovacsova, Judita (Researcher)
  • Krenosz, K. J. (Researcher)
  • Krivic, Denis (Researcher)
  • Kühr, Thomas (Researcher)
  • Piringer, Gudrun (Researcher)
  • Popp, Henning Detlef (Researcher)
  • Schneeweiß, Bruno (Researcher)
  • Schwarz, Heike (Researcher)
  • Solomianyi, Oleksii (Researcher)
  • Stegemann, Maike (Researcher)
  • Schmitt, Clemens (PI)

Project: Funded research › FWF - Austrian Science Fund

Project Details

Description

Age-adjusted high-dose chemotherapy followed by autologous stem cell transplantation or conventional chemotherapy with R-MP as first-line treatment in elderly primary CNS lymphoma patients - the randomized phase III PRIMA-CNS trial
StatusActive
Effective start/end date21.08.2024 → 20.08.2027

Fields of science

  • 302024 Haematology
  • 302055 Oncology